We are live on ! Find out more
ALDX icon

Aldeyra Therapeutics
ALDX

98 hedge funds and large institutions have $155M invested in Aldeyra Therapeutics in 2020 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 29 increasing their positions, 24 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 12

21% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 24

13% more funds holding

Funds holding: 87 → 98 (+11)

3.93% less ownership

Funds ownership: 61.63% → 57.71% (-3.9%)

11% less capital invested

Capital invested by funds: $174M → $155M (-$19.1M)

60% less funds holding in top 10

Funds holding in top 10: 5 → 2 (-3)

68% less call options, than puts

Call options by funds: $689K | Put options by funds: $2.18M

Holders
98
Holders Change
+11
Holders Change %
+12.64%
% of All Funds
1.73%
Holding in Top 10
2
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-60%
% of All Funds
0.04%
New
24
Increased
29
Reduced
24
Closed
12
Calls
$689K
Puts
$2.18M
Net Calls
-$1.49M
Net Calls Change
-$2.1M

Top Buyers

1
Citadel Advisors
Citadel Advisors
Florida
+$2.08M
2
Millennium Management
Millennium Management
New York
+$1.58M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
+$1.52M
4
ECM
ExodusPoint Capital Management
New York
+$899K
5
Deutsche Bank
Deutsche Bank
Germany
+$838K

Top Sellers

1
ACP
Acuta Capital Partners
California
-$10.2M
2
Invesco
Invesco
Georgia
-$4.63M
3
GTC
Ghost Tree Capital
New York
-$4.21M
4
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
-$1.44M
5
PM
Prosight Management
Texas
-$1.29M
Name Holding Trade Value Shares
Change 		Change in
Stake
E
51
Ergoteles
New York
$240K +$246K +34,985 New
TFA
52
Tobias Financial Advisors
Florida
$234K – – –
Acadian Asset Management
53
Acadian Asset Management
Massachusetts
$233K +$239K +33,986 New
SSA
54
Schonfeld Strategic Advisors
New York
$232K -$523K -74,446 -69%
AGM
55
Alpine Global Management
New York
$191K +$196K +27,873 New
IAIM
56
International Assets Investment Management
Florida
$187K +$192K +27,315 New
AG
57
Algert Global
California
$186K – – –
SG Americas Securities
58
SG Americas Securities
New York
$182K +$187K +26,578 New
QSS
59
Quantitative Systematic Strategies
Florida
$175K -$121K -17,180 -40%
WCA
60
Windsor Creek Advisors
Vermont
$175K +$35.1K +5,000 +24%
CSS
61
Cubist Systematic Strategies
Connecticut
$166K +$162K +23,102 +2,000%
RJA
62
Raymond James & Associates
Florida
$156K – – –
OMC
63
Old Mission Capital
Illinois
$148K +$152K +21,650 New
State Street
64
State Street
Massachusetts
$142K +$11.2K +1,600 +8%
MFS
65
Mirabella Financial Services
United Kingdom
$141K -$20.5K -2,913 -12%
HP
66
Hikari Power
Japan
$137K – – –
JF
67
Jump Financial
Illinois
$137K +$140K +19,900 New
KAS
68
Kestra Advisory Services
Texas
$135K +$139K +19,767 New
JCM
69
JS Capital Management
New York
$132K +$135K +19,200 New
Charles Schwab
70
Charles Schwab
California
$125K – – –
BFM
71
Boothbay Fund Management
New York
$125K +$128K +18,277 New
OGC
72
One68 Global Capital
New York
$123K +$126K +17,899 New
Simplex Trading
73
Simplex Trading
Illinois
$114K +$111K +15,803 +1,674%
FDCDDQ
74
Federation des caisses Desjardins du Quebec
Quebec, Canada
$104K +$19.5K +2,775 +22%
CIBC World Market
75
CIBC World Market
Ontario, Canada
$103K – – –
1 2
3
4 5

ALDX Hedge Fund Activity: Q4 2020 in Review

98 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Aldeyra Therapeutics (ALDX) for Q4 2020, worth a combined $155M — down 11% from $174M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new ALDX positions and 12 closed out — a net gain of 12 holders — while 29 added to existing stakes and 24 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $2.08M. The largest seller was Acuta Capital Partners, cutting an estimated $10.2M.

  • 98 institutional investors held Aldeyra Therapeutics (ALDX) as of Q4 2020, up from 87 in Q3 2020.
  • Funds reported $155M of Aldeyra Therapeutics stock for Q4 2020, down 11% quarter-over-quarter.
  • 24 funds opened new Aldeyra Therapeutics positions in Q4 2020 and 12 closed out, a net change of +12 holders.
  • The largest Aldeyra Therapeutics buyer in Q4 2020 was Citadel Advisors, an estimated $2.08M added.
  • The largest Aldeyra Therapeutics seller in Q4 2020 was Acuta Capital Partners, an estimated $10.2M sold.

Based on aggregated 13F filings for Q4 2020.